Why there's a debate over the new quarantine center for Americans at risk of Ebola

A contentious debate has emerged in Kenya regarding a new U.S.-built Ebola quarantine center in Nanyuki, approximately 120 miles from the capital, Nairobi. This facility is designated for observing American citizens returning from high-risk Ebola zones in the Democratic Republic of Congo, South Sudan, or Uganda. The stated U.S. rationale is to mitigate the risk of the virus entering the United States, with the State Department highlighting Kenya's proximity and limited regional airport capabilities as key selection factors.

However, the initiative has sparked considerable local opposition and an anti-American backlash. Residents and civil society groups have staged protests, accusing the Kenyan government of a lack of transparency and expressing deep-seated fears that the center could introduce Ebola into the country. These demonstrations have, at times, turned violent, with police deploying tear gas and, tragically, two protesters being fatally shot in a previous incident. Despite Kenyan President William Ruto's approval of the facility as a bilateral partnership, a high court has issued a ruling against it, citing concerns over constitutional safeguards and the potential exposure of the public to significant health risks.

The U.S. Secretary of State, Marco Rubio, initially framed the facility as a crucial measure to protect the American populace from Ebola, though he later clarified that sick Americans could be repatriated for treatment. Critically, public health experts, including those with firsthand experience from the 2014 West African Ebola outbreak, have voiced strong reservations. Dr. Nahid Bhadelia and Dr. Craig Spencer argue that this approach is counterproductive, asserting that it fosters resentment globally and does not inherently enhance U.S. security. Spencer likened it to a 'build the wall, but for viruses' strategy, highlighting perceptions of 'colonial decision making' that disregard local concerns. The State Department states that individuals with high-risk exposure would voluntarily relocate to the facility for a 21-day monitoring period before becoming contagious. If symptoms develop, transfer to Europe or the U.S. for treatment would be considered, though to date, no American has utilized the Kenyan facility.